MELATONIN

Child

University Medical Centre LjubljanaSmall moleculeN/ADormant

D

30/ 100

Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence: 15/ 100
Competitive Position: 81/ 100

Competitive context

9 Active assets in the Child cohort.

Asset / Sponsor	Phase	Rating
Thiamine Mahidol University	Phase 4	BB
Emicizumab Kathelijn Fischer	Phase 4	B
Bedamustine Children's Cancer Group, China	Phase 2/3	B
Inno-206 Children's Cancer Group, China	Phase 2/3	B
PREDNISONE TABLETS Children's Cancer Group, China	Phase 2/3	B

View all 12 →

Same molecule, other indications

MELATONIN is also rated in:

traumatic brain injuryDormant

BBB

Indicative ·

74 / 100

bipolar disorderDormant

BBB

Indicative ·

72 / 100

circadian rhythm sleep disorderDormant

BB

Indicative ·

69 / 100

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.